Baxion
ScreeningTagsAlerts

Eikon Therapeutics, Inc.

EIKN

Financials

10-QQ2 ended 06/30/2608/13/2610-QQ1 ended 03/31/2605/11/2610-KFY 202503/30/26

Disclosures

8-KCurrent report10/26/268-KCurrent report10/23/268-KCurrent report08/14/268-KCurrent report08/13/268-KCurrent report08/03/26

Prospectuses and Registrations

S-8Registration of securities for employees02/06/26424B4Prospectus02/05/26S-1MEFProspectus / registration02/04/26S-1/ARegistration statement (amended)01/28/26S-1Registration statement (IPO)01/09/26

Proxies

No matching filings.

Ownership

SC 13G/ABeneficial ownership (amended)10/07/26SC 13G/ABeneficial ownership (amended)10/02/26Form 4Insider transaction09/08/26SC 13G/ABeneficial ownership (amended)08/06/26Form 3Initial insider ownership06/15/26

Other

CERTCEO/CFO certification02/04/26EFFECTRequest for effectiveness01/30/268-A12B8-A12B01/28/26DRS/ADRS/A12/12/25DRS/ADRS/A09/26/25

Latest Filings

8-KCurrent report10/26/268-KCurrent report10/23/268-KCurrent report08/14/2610-QQ2 ended 06/30/2608/13/268-KCurrent report08/13/26

Ownership

SC 13G/ABeneficial ownership (amended)10/07/26SC 13G/ABeneficial ownership (amended)10/02/26Form 4Insider transaction09/08/26SC 13G/ABeneficial ownership (amended)08/06/26Form 3Initial insider ownership06/15/26
  • Baxion © 2026
  • Terms
  • Privacy
  • Contact